PAOG - New Independent CBD Research Appears To Support PAOG RespRx Research
RespRx is a cannabis treatment under development for Chronic Obstructive Pulmonary Disease (COPD derived from a patented cannabis extraction method- U.S. Patent No.
- RespRx is a cannabis treatment under development for Chronic Obstructive Pulmonary Disease (COPD derived from a patented cannabis extraction method- U.S. Patent No.
- In an initial scientific evaluation as a treatment for COPD, RespRx has demonstrated effecting significant increases in respiration rate, tidal volume and inspiratory air flow rate.
- Overall data from the evaluation demonstrated that RespRx can significantly improve inspiratory lung functions in instances of moderate pulmonary fibrosis.
- The Company undertakes no duty to revise or update any forward-looking statements to reflect events or circumstances after the date of this release.